Hydrogel Drug Systems
Hydrogel Drug Systems - Related Videos
10:28
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
0 Views •
Cited by 21 •
2015
Supramolecular hydrogelators based on ureido-pyrimidinones allow full control over the macroscopic gel properties and the sol–gel switching behavior using pH. Here, we present a protocol for formulating and injecting such a supramolecular hydrogelator via a catheter delivery system for local delivery directly in relevant areas in the pig heart.
16:06
Fabrication of Micropatterned Hydrogels for Neural Culture Systems using Dynamic Mask Projection Photolithography
0 Views •
Cited by 46 •
2011
Simple techniques are described for the rapid production of microfabricated neural culture systems using a digital micromirror device for dynamic mask projection lithography on regular cell culture substrates. These culture systems may be more representative of natural biological architecture, and the techniques described could be adapted for numerous applications.
08:33
Hydrogel Synthesis
0 Views •
2023
Source: Amber N. Barron, Ashlea Patterson, and Taylor D. Sparks, Department of Materials Science and Engineering, The University of Utah, Salt Lake City, UT Hydrogels are a versatile class of cross-linked polymers produced through relatively simple procedures and with generally inexpensive materials. They can be formed from solution and involve a polymer backbone formed from monomer reagents, an initiator which makes the polymer reactive and a crosslinking species which binds the polymer chains...
09:47
FRET Imaging in Three-dimensional Hydrogels
0 Views •
Cited by 3 •
2016
Förster resonance energy transfer (FRET) imaging is a powerful tool for real-time cell biology studies. Here a method for FRET imaging cells in physiologic three-dimensional (3D) hydrogel microenvironments using conventional epifluorescence microscopy is presented. An analysis for ratiometric FRET probes that yields linear ratios over the activation range is described.
01:18
Transdermal Drug Delivery Systems
0 Views •
2026
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
FAQs
These environmental conditions can change how the hydrated polymer network swells or reorganizes. Increased or decreased swelling affects the pathways available for drug diffusion, while enzymatic activity may contribute to polymer breakdown. As a result, release can respond to local physiological conditions rather than occurring at a single fixed rate, supporting treatment designs tailored to specific anatomical environments.
Drug release may occur through diffusion, polymer degradation, or changes in the hydrogel network. Diffusion allows the compound to move through water-filled spaces, whereas degradation can progressively open or remove parts of the matrix. Network changes caused by environmental conditions provide another control point, allowing researchers to adjust how quickly and where therapeutic exposure occurs.
Hydrogel composition determines how the matrix responds to its surroundings and how the drug leaves the system. Researchers can therefore adjust release behavior to match therapeutic and anatomical requirements. This design flexibility matters clinically because a wound, injection site, implant location, or tissue-engineering environment may require different levels of localization, persistence, and exposure control.
A hydrogel approach may be considered when treatment benefits from sustained delivery, localized therapy, or reduced systemic exposure. Its potential value is greatest when repeated dosing is undesirable or when the therapeutic effect should remain near a specific site. Clinical research examines these systems across wound care, injectable formulations, implantable devices, and tissue-engineering applications.
Clinical research explores hydrogel drug systems as wound-care materials, injectable formulations, implantable devices, and components of tissue-engineering strategies. Each format places different demands on the matrix and release profile. The system can be tailored to the therapeutic compound and the anatomical site, helping align delivery behavior with the intended treatment setting rather than applying one design universally.
Localized placement can concentrate treatment near the intended anatomical site while potentially limiting exposure elsewhere in the body. Sustained release may also reduce the need for frequent dosing by maintaining therapeutic delivery over time. These potential outcomes make hydrogels relevant to clinical research focused on controlling drug distribution, improving treatment practicality, and supporting site-specific therapy.